Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Strong Trading Volume – Here’s What Happened

Posted by Teresa Graham on Jul 23rd, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw an uptick in trading volume on Thursday . Approximately 751,299 shares changed hands during mid-day trading, an increase of 420% from the previous session’s volume of 144,600 shares.The stock last traded at $12.25 and had previously closed at $12.46.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, Fresenius SE & Co. has a consensus rating of “Buy”.

Get Our Latest Analysis on Fresenius SE & Co.

Fresenius SE & Co. Stock Down 1.7%

The business has a fifty day moving average of $11.47 and a 200 day moving average of $12.88. The stock has a market capitalization of $27.60 billion, a price-to-earnings ratio of 16.33 and a beta of 0.63. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.27 and a quick ratio of 0.98.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. The company had revenue of $6.75 billion during the quarter, compared to analysts’ expectations of $6.79 billion. As a group, equities analysts predict that Fresenius SE & Co. will post 1.03 earnings per share for the current year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.